1. AHRO : Austin Health Research Online

Matthew R Peverelle

View Statistics Email Alert

Profile

Loading... 2 0 5 0 false
Credit Name
Matthew R Peverelle
Full Name
Peverelle, Matthew R
 
Department
 
ORCID
Loading... 3 0 5 0 false

Publications

Results 1-5 of 5 (Search time: 0.003 seconds).

Publication YearTitleAuthor(s)
111-Apr-2020Letter Re: Safety of Combination Biologic and Antirejection Therapy Post-liver Transplantation in Patients With Inflammatory Bowel DiseasePeverelle, Matthew R ; Mills, Chris; Testro, Adam G ; Gow, Paul J ; De Cruz, Peter P 
231-Mar-2020Ustekinumab is a safe and effective biologic agent for Crohn's disease in a Liver Transplant patient.Peverelle, Matthew R ; Asadi, Khashayar; De Cruz, Peter P 
320-Feb-2020Letter Re: Safety of Combination Biologic and Antirejection Therapy Post-liver Transplantation in Patients With Inflammatory Bowel Disease.Peverelle, Matthew R ; Mills, Christopher D; Testro, Adam G ; Gow, Paul J ; De Cruz, Peter P 
416-Jan-2020Activity of Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis Predicts Poorer Clinical Outcomes.Peverelle, Matthew R ; Paleri, Sarang; Hughes, Jed ; De Cruz, Peter P ; Gow, Paul J 
5Jan-2019Higher long-term adherence to statins in rural patients at high atherosclerotic risk.Peverelle, Matthew R ; Baradi, Arul; Paleri, Sarang; Lee, Yun Suk; Sultani, Rohullah; Toukhsati, Samia R ; Hare, David L ; Janus, Edward; Wilson, Andrew M